Evidence map›Paper›PMID 24195963›Full record

ArticleGenes and immunity2014

Using the emerging Collaborative Cross to probe the immune system.

J Phillippi, Y Xie, D R Miller, T A Bell, Z Zhang, A B Lenarcic, D L Aylor, S H Krovi, D W Threadgill, F Pardo-Manuel de Villena and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Genes and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Genetic and immunological contributors to virus-induced paralysis.Brain, behavior, & immunity - health · 2021
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

J PhillippiDepartment of Immunobiology, University of Arizona, Tucson, AZ, USA.
Y XieDepartment of Genetics, University of North Carolina, Chapel Hill, NC, USA.
D R Miller1] Department of Genetics, University of North Carolina, Chapel Hill, NC, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
T A Bell1] Department of Genetics, University of North Carolina, Chapel Hill, NC, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Z ZhangDepartment of Computer Science, University of North Carolina, Chapel Hill, NC, USA.
A B LenarcicDepartment of Genetics, University of North Carolina, Chapel Hill, NC, USA.
D L Aylor1] Department of Genetics, University of North Carolina, Chapel Hill, NC, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
S H KroviDepartment of Immunobiology, University of Arizona, Tucson, AZ, USA.
D W ThreadgillDepartment of Genetics, North Carolina State University, Raleigh, NC, USA.
F Pardo-Manuel de Villena1] Department of Genetics, University of North Carolina, Chapel Hill, NC, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
W WangDepartment of Computer Science, and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA.
W Valdar1] Department of Genetics, University of North Carolina, Chapel Hill, NC, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.ORCID 0000000224190430
J A FrelingerDepartment of Immunobiology, University of Arizona, Tucson, AZ, USA.ORCID 0000000225036267
University of North Carolina at Chapel Hill · USUniversity of Arizona · USNorth Carolina State University · USUniversity of California, Los Angeles · US

Funding

UNC and PERLEGEN, IncP50GM076468 · NIGMS · JACKSON LABORATORY · PI SMITH, RANDY VON · 2006 to 2015
$31.0M
Systems Genetic Analysis of Multi-parent CrossesR01GM070683 · NIGMS · JACKSON LABORATORY · PI BROMAN, KARL W, CHURCHILL, GARY A · 2004 to 2022
$6.8M
Modeling heterogeneity for safe cancer prevention and detectionU01CA105417 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THREADGILL, DAVID W. · 2004 to 2013
$6.7M
An Interdisciplinary program for systems genomics of complex behaviorsP50MH090338 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PARDO-MANUEL DE VILLENA, FERNANDO · 2009 to 2010
$6.0M
An Interdisciplinary program for systems genomics of complex behaviorsP50HG006582 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PARDO-MANUEL DE VILLENA, FERNANDO · 2011 to 2013
$2.6M
Statistical Modeling of Complex Traits in Genetic Reference Super-PopulationsR01GM104125 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI VALDAR, WILLIAM · 2012 to 2016
$1.2M
System Genetics of Male Infertility in the Collaborative CrossF32GM090667 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AYLOR, DAVID LAWRENCE · 2010 to 2011
$96k
NCI NIH HHS CA105417NHGRI NIH HHS P50 MH0903380/HG006582NIGMS NIH HHS F32 GM090667NIGMS NIH HHS GM070683NIGMS NIH HHS GM104125NIGMS NIH HHS P50 GM076468NIGMS NIH HHS R01 GM070683NIGMS NIH HHS R01 GM104125NIMH NIH HHS P50 MH090338
6 · The paper itself

Abstract

The Collaborative Cross (CC) is an emerging panel of recombinant inbred (RI) mouse strains. Each strain is genetically distinct but all descended from the same eight inbred founders. In 66 strains from incipient lines of the CC (pre-CC), as well as the 8 CC founders and some of their F1 offspring, we examined subsets of lymphocytes and antigen-presenting cells. We found significant variation among the founders, with even greater diversity in the pre-CC. Genome-wide association using inferred haplotypes detected highly significant loci controlling B-to-T cell ratio, CD8 T-cell numbers, CD11c and CD23 expression. Comparison of overall strain effects in the CC founders with strain effects at QTL in the pre-CC revealed sharp contrasts in the genetic architecture of two traits with significant loci: variation in CD23 can be explained largely by additive genetics at one locus, whereas variation in B-to-T ratio has a more complex etiology. For CD23, we found a strong QTL whose confidence interval contained the CD23 structural gene Fcer2a. Our data on the pre-CC demonstrate the utility of the CC for studying immunophenotypes and the value of integrating founder, CC and F1 data. The extreme immunophenotypes observed could have pleiotropic effects in other CC experiments.

Indexed as

Quantitative Trait LociAnimalsB-LymphocytesCD11c AntigenCD8-Positive T-LymphocytesGenetic VariationGenome-Wide Association StudyHaplotypesImmunogeneticsLymphocyte SubsetsMiceMice, Inbred StrainsReceptors, IgET-LymphocytesCD11c AntigenReceptors, IgE

Identifiers

PMID24195963
PMCPMC4004367
OpenAlexW2058792460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.